Correlation Between Zurich Insurance and BB Biotech

Can any of the company-specific risk be diversified away by investing in both Zurich Insurance and BB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zurich Insurance and BB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zurich Insurance Group and BB Biotech AG, you can compare the effects of market volatilities on Zurich Insurance and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zurich Insurance with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zurich Insurance and BB Biotech.

Diversification Opportunities for Zurich Insurance and BB Biotech

0.24

Correlation Coefficient

Zurich Insurance  BB Biotech

Modest diversification

The 3 months correlation between Zurich and BION is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Zurich Insurance Group and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and Zurich Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zurich Insurance Group are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of Zurich Insurance i.e., Zurich Insurance and BB Biotech go up and down completely randomly.

Pair Corralation between Zurich Insurance and BB Biotech

Assuming the 90 days trading horizon Zurich Insurance is expected to generate 49.97 times less return on investment than BB Biotech. But when comparing it to its historical volatility, Zurich Insurance Group is 1.6 times less risky than BB Biotech. It trades about 0.01 of its potential returns per unit of risk. BB Biotech AG is currently generating about 0.34 of returns per unit of risk over similar time horizon. If you would invest  3,375  in BB Biotech AG on September 8, 2025 and sell it today you would earn a total of  1,210  from holding BB Biotech AG or generate 35.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Zurich Insurance Group  vs.  BB Biotech AG

Zurich Insurance

Risk-Adjusted Performance

Weakest

Over the last 90 days Zurich Insurance Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Zurich Insurance is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

BB Biotech AG

Risk-Adjusted Performance

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in BB Biotech AG are ranked lower than 27 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, BB Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Zurich Insurance and BB Biotech

The main advantage of trading using opposite Zurich Insurance and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zurich Insurance position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.

The idea behind Zurich Insurance Group and BB Biotech AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.